Prof. Dr. Vesile Altınyazar

Prof Dr. Vesile Altınyazar, 2001 yılında Süleyman Demirel Üniversitesi, Tıp Fakültesi Ruh Sağlığı ve Hastalıkları Anabilim dalında psikiyatri ihtisasına başladı.

Uzmanlık eğitimi esnasında İstanbul Üniversitesi İstanbul Tıp Fakültesinde kısa süreli çalışmaları oldu. “İntihar Girişiminde Bulunanlar Arasında TPH, 5-HTT, MAO-A Genlerinin Polimorfizmlerinin Etkileri: Gen-Çevre Etkileşiminin İncelenmesi” tezi ile 2006 yılında Psikiyatri uzmanlık eğitimini tamamladı.

Sağlık Bakanlığı, Siirt Devlet Hastanesi, Ruh Sağlığı ve Hastalıkları Kliniğinde 2006-2008 yılları arasında mecburi hizmet yükümlülüğünü tamamladı.

2008 yılında Adnan Menderes Üniversitesi, Tıp Fakültesi, Ruh Sağlığı ve Hastalıkları Anabilim Dalında Yardımcı doçent olarak göreve başladı, 2014 yılında Doçent, 2019 yılında psikiyatri Profesörü oldu. 2008’den itibaren psikoz biriminin sorumluluğunu yürüttü.

2020 yılından itibaren EMDR (Göz Hareketleriyle Duyarsızlaştırma ve Yeniden İşleme,) terapisi alanında Avrupa EMDR derneği tarafından akredite terapist olarak çalışmaktadır. Halen Adnan Menderes Üniversitesi, Tıp Fakültesi, Ruh Sağlığı ve Hastalıkları Anabilim Dalında çalışmaya devam etmektedir.

Yayınlar:

1. Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. Erzin G, Pries LK, van Os J, Fusar-Poli L, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O'Donovan MC, Rutten BPF, Guloksuz S.Eur Psychiatry. 2021 Mar 19;64(1):e25. doi: 10.1192/j.eurpsy.2021.19.
2. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings. Velthorst E, Mollon J, Murray RM, de Haan L, Germeys IM, Glahn DC, Arango C, van der Ven E, Di Forti M, Bernardo M, Guloksuz S, Delespaul P, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Santos JL, Jiménez-López E, Sanjuan J, Aguilar EJ, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Atbaşoğlu C, Saka MC, Üçok A, Alptekin K, Akdede B, Binbay T, Altınyazar V, Ulaş H, Yalınçetin B, Gümüş-Akay G, Beyaz BC, Soygür H, Cankurtaran EŞ, Kaymak SU, Maric NP, Mihaljevic MM, Petrovic SA, Mirjanic T, Del-Ben CM, Ferraro L, Gayer-Anderson C, Jones PB, Jongsma HE, Kirkbride JB, La Cascia C, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Morgan C, Quattrone D, Menchetti M, Selten JP, Szöke A, Tarricone I, Tortelli A, McGuire P, Valmaggia L, Kempton MJ, van der Gaag M, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Nelson B, McGorry P, Pantelis C, Krebs MO, Ruhrmann S, Sachs G, Rutten BPF, van Os J, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, Bruggeman R, van Beveren NJ, Luykx JJ, Cahn W, Simons CJP, Kahn RS, Schirmbeck F, van Winkel R; EU-GEI High Risk Study, Reichenberg A.Mol Psychiatry. 2021 Aug;26(8):4529-4543. doi: 10.1038/s41380-020-00969-z.
3. Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study.Fusar-Poli L, Pries LK, van Os J, Erzin G, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Üçok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Aguglia E, Arango C, O'Donovan M, Rutten BPF, Guloksuz S.Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 8;113:110440. doi: 10.1016/j.pnpbp.2021.110440. Epub 2021 Sep 16.
4. A replication study of JTC bias, genetic liability for psychosis and delusional ideation.
   Henquet C, van Os J, Pries LK, Rauschenberg C, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran ES, Kaymak SU, Mihaljevic MM, Petrovic SS, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Arango C, O'Donovan M, Rutten BPF, Gülöksüz S.Psychol Med. 2020 Oct 13:1-7. doi: 10.1017/S0033291720003578.
5. Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway. van Os J, Pries LK, Ten Have M, de Graaf R, van Dorsselaer S, Delespaul P, Bak M, Kenis G, Lin BD, Luykx JJ, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Arango C, O'Donovan M, Rutten BPF, Guloksuz S.Psychol Med. 2020 Oct 19:1-13. doi: 10.1017/S0033291720003748. Online ahead of print.
6. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study. van Os J, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome Investigators (GROUP), Arango C, O'Donovan M, Rutten BPF, Guloksuz S.Psychol Med. 2020 Aug;50(11):1884-1897. doi: 10.1017/S003329171900196X.
7. White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?
   Schepers E, Lousberg R, Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Şahin Cankurtaran E, Ulusoy Kaymak S, Mihaljevic MM, Andric Petrovic S, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Luis Santos J, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Can Saka M, Arango C, Rutten BPF, van Os J.Front Psychiatry. 2019 Sep 25;10:676. doi: 10.3389/fpsyt.2019.00676. eCollection 2019.
8. Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study. Pries LK, Lage-Castellanos A, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altinyazar V, Yalinçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O'Donovan M, Rutten BPF, van Os J, Guloksuz S.Schizophr Bull. 2019 Sep 11;45(5):960-965. doi: 10.1093/schbul/sbz054.
9. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study. Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran E, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşog Lu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O'Donovan M, Rutten BPF, van Os J.World Psychiatry. 2019 Jun;18(2):173-182. doi: 10.1002/wps.20629.
10. Bone mineral density in patients treated with antipsychotics. Cengiz A, Altınyazar V, Manoğlu BG, Vahapoğlu F, Kocabaş O, Kurt Ömürlü İ, Yürekli Y. Anatolian Journal of Psychiatry 2019; 20(2): 182-188
    Riluzole augmentation in treatment-resistant schizoaffective disorder with comorbid obsessive-compulsive disorder: a case study. Tunagür MT, Bilgen N, Altınyazar V. Psychiatry And Clinical Psychopharmacology, 2018, Vol. 28, No. S1, 204. A.
11. Coconut oil as a nutritional supplementation in the treatment of schizoaffective disorder: case series. Altınyazar V, Karimova G, Tunagür MT. Psychiatry And Clinical Psychopharmacology, 2018, Vol. 28, No. S1, 213. A.
12. Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature.Altınyazar V, Kiylioglu N.Ther Adv Psychopharmacol. 2016 Aug;6(4):263-8. doi: 10.1177/2045125316646064. Epub 2016 May 16.
13. The Red Blood Cell Acetylcholinesterase Levels of Depressive Patients with Suicidal Behavior in an Agricultural Area.Altinyazar V, Sirin FB, Sutcu R, Eren I, Omurlu IK.Indian J Clin Biochem. 2016 Oct;31(4):473-9. doi: 10.1007/s12291-016-0558-9.
    Relation of the Allelic Variants of Multidrug Resistance Gene to Agranulocytosis Associated With Clozapine. Yağcioğlu AE, Gökhan Y, Ayhan Y, Karaca RÖ, Çevik L, Müderrisoğlu A, Göktaş MT, Eni N, Yazici MK, Bozkurt A, Babaoğlu MO, The authors in the Clozapine-Associated Leukopenia/Agranulocytosis Study Group are the following: V.Altinyazar, M. Aydin, Y. Görgülü, B.B. Kivircik Akdede, K. Alptekin, A. Üçok, A.E. Danaci, B.Ç. İlhan, S. Ulusoy, H. Gürsoy, H. Özdemir, M. Çelik, F.Ö. Orhan, H. Ozan and İ. Kaygisiz. Journal of Clinical Psychopharmacology. 36(4):354, 2016. doi: 10.1097/JCP.0000000000000495.
14. The temperament and character personality profile of the glaucoma patient. Çakmak H, Altinyazar V, Yilmaz SG, Ömürlü İK, Kocatürk T, Yazici A, Değirmenci C, Dündar SO, Ates H.BMC Ophthalmol. 2015 Oct 1;15:125. doi: 10.1186/s12886-015-0117-9.
15. No association of Catechol-O-Methyltransferase (COMT) Gene Haplotypes in Patients with Schizophrenia in a Turkish Sample Altinyazar V, Gunderici A, Tinaz E, Kirci C. Bülteni-Bulletin of Clinical Psychopharmacology, (2015) 25:2, 129-135, DOI: 10.5455/bcp.20130127020909
16. Eating disorders and psychosis. Altınyazar V, Maner F, Anatolian Journal of Psychiatry. Anatolian Journal of Psychiatry 2014; 15:84-88
17. “Personality traits in schizophrenia patients at remission phase and their first degree relatives: a dopaminergic and glutamatergic genes polymorphisms study”. Altınyazar V, Gunderici A, Bulletin of Clinical Psychopharmacology 2013;23(2):138-48 DOI: 10.5455/bcp.20130308015536
18. Facets of Self in Schizophrenia: The Reliability and Accuracy of Trait Self-Knowledge. Klein SB, Altinyazar V, and Metz MA, Clinical Psychological Science, published online 26 February 2013 DOI: 10.1177/2167702612474263
19. A cross-cultural investigation of suicidal behavior and attitudes in Austrian and Turkish medical students. Eskin M, Voracek M, Stieger S, Altinyazar V.Soc Psychiatry Psychiatr Epidemiol. 2011 Sep;46(9):813-23. doi: 10.1007/s00127-010-0254-7.
20. Anorexia nervosa and Wernicke Korsakoff's syndrome: atypical presentation by acute psychosis. Altinyazar V, Kiylioglu N, Salkin G.Int J Eat Disord. 2010 Dec;43(8):766-9. doi: 10.1002/eat.20783.
    Risperidone-induced rabbit syndrome in mood disorder. Eren I, Ozcankaya R, Altinyazar V. Eur Psychiatry. 2004 Nov;19(7):452-3. doi:10.1016/j.eurpsy.2004.06.022.PMID: 15504657

Prof Dr. Vesile Altınyazar, 1996 yılında Uludağ Üniversitesi Tıp Fakültesinden mezun oldu.

Uludağ Üniversitesi, Tıp Fakültesi Farmakoloji Anabilim Dalında 2000 yılında Farmakoloji uzmanlık eğitimini tamamlamasının akabinde Harvard Üniversitesi, Brigham and Women's Hospital, Nöroloji bölümü nöroscience laboratuvarında kısa bir süre çalıştı.

2001 yılında Süleyman Demirel Üniversitesi, Tıp Fakültesi Ruh Sağlığı ve Hastalıkları Anabilim dalında psikiyatri ihtisasına başladı.